establishmentlabs.com - רווח לפני ניכוי ריבית, מסים, בלאי ופחת ESTA

Establishment Labs leads the medical aesthetics sector by integrating RFID chips and 3D planning into Motiva implants. Changes in EBITDA_Co confirm this growth, where the parameter value equals 0.00. Stable demand for silicone products provides the company with a reliable cash flow. The brand's premium status and focus on safety make its products the priority choice for the world's leading plastic surgery clinics.

Establishment Labs produces implants for aesthetic medicine, the demand for which depends on patients' disposable income. By analyzing EBITDA, an investor tracks real sales efficiency regardless of the debt load. This metric excludes the impact of depreciation and interest, stripping the operating result of accounting adjustments. The trend of this indicator reveals the business's sensitivity to macroeconomic fluctuations, allowing for an objective assessment of the asset's fundamental stability.